According to the creators, the drug PBOX-15 is able to kill cancer cells in adult patients with a poor prognosis, which did not help the other treatment. The development of drugs carried a team of scientists from Trinity College in Dublin, in cooperation with Italian universities in Siena. The data published in the journal Cancer Research.
Professor Mark Lawler of Trinity College School of Medicine has warned that while PBOX-15 is at the stage of early clinical trials. It will take another three to five years before the drug will enter the market and will be applied for the treatment of blood cancer .
"Now we have to make sure there is whether he has any side effects, - says Professor Lawler. - Then the medication will be put into production. Its efficiency is impressive. We want to give hope to patients leukemia ".
Mark Lawler, who manages the development, said that the drug attacks and destroys the "backbone" of cells leukemia in those samples, which were obtained from patients. With PBOX-15 also effectively treated chronic lymphocytic leukemia - the type blood cancer Which is the most common in the Western world.
The researchers believe that their medication is significantly more effective than currently used fludarabine, as it kills the harmful cells that can withstand any modern medicines. The representative of the Irish Cancer Community John McCormack believes that the tests PBOX-15 is necessary as soon as possible to transfer from the laboratory to the hospital, where he was waiting for patients leukemia .
Industry News
Go back to the main page
No comments:
Post a Comment